Key result
Pretransplant obesity (BMI ≥ 25 kg/m²) was an independent risk factor for death-censored allograft loss (adjusted HR 1.511) in Korean kidney transplant recipients.
Why the study?
Does pretransplant obesity increase the risk of death-censored allograft loss, cardiovascular events, or all-cause mortality in kidney transplant recipients?
Cohort (n=9,130)
Yes
Does pretransplant obesity increase the risk of death-censored allograft loss, cardiovascular events, or all-cause mortality in kidney transplant recipients?
Hazard Ratio: 1.511 (95% CI 1.063–2.148)
Absolute Event Rate: 3.7% vs 2.6%
p-value: p=0.021
Pretransplant obesity (BMI ≥ 25 kg/m²) in Asian kidney transplant recipients is independently associated with an increased risk of death-censored allograft loss, highlighting the importance of weight management prior to transplantation.
Obesity may raise death-censored graft loss risk in Asian recipients; leaves open whether pretransplant weight interventions improve outcomes.
BACKGROUND: , and posttransplant outcomes in Korean kidney transplant recipients (KTRs). METHODS: We investigated prospective nationwide cohort data from the Korean Organ Transplantation Registry (KOTRY) from 2014 to 2021. KTRs were categorized into 4 groups based on pretransplant BMI: underweight (< 18.5), normal weight (18.5-22.9), overweight (23-24.9), and obesity (≥ 25). Posttransplant outcomes, including death-censored allograft loss, cardiovascular events, and all-cause mortality, were compared using Kaplan-Meier curves with the log-rank test. Cox proportional hazard regression analysis was employed to assess associations between BMI and posttransplant outcomes. RESULTS: A total of 9,130 KTRs were finally analyzed. The mean age was 49.9 ± 11.6 and 60.2% of KTRs were male. The prevalence of obesity in KTRs was 28.6% and continued to increase (24.8% in 2014 to 32.5% in 2021). Obese KTRs were characterized by male predominance, shorter dialysis vintage, and more diabetes as primary kidney disease. Kaplan-Meier curve showed a significant difference in death-censored allograft loss among BMI groups (P = 0.007). Obesity (BMI ≥ 25 kg/m²) was as an independent risk factor for death-censored allograft loss (adjusted hazard ratio 1.511, 95% confidence interval 1.063-2.148, P = 0.021), but not for cardiovascular events or mortality. CONCLUSIONS: Our study evaluated BMI across a spectrum of categories, suggesting that obesity is an independent risk factor for graft survival in KTRs. Risk stratification using BMI and strategies to prevent obesity should be considered in the preparation for kidney transplantation. CLINICAL TRIAL NUMBER: Not applicable.
No takes yet. Share an insight, caveat, or question.
Cho et al. (2025) conducted a cohort in End-stage kidney disease (n=9,130). Pretransplant obesity (BMI ≥ 25 kg/m²) vs. Normal weight (BMI 18.5–22.9 kg/m²) was evaluated on Death-censored allograft loss (aHR 1.511, 95% CI 1.063-2.148, p=0.021). Pretransplant obesity (BMI ≥ 25 kg/m²) was an independent risk factor for death-censored allograft loss (adjusted HR 1.511) in Korean kidney transplant recipients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: